Merrell Dow Pharmaceuticals Inc. v. Thompson Ex Rel. Thompson

1986-07-07

Headline: Federal court access limited: Court ruled that state lawsuits relying on federal safety rules do not give federal courts jurisdiction when Congress withheld a federal private remedy, keeping many drug-injury cases in state courts.

Holding: The Court held that a state-law claim alleging violation of a federal statute does not "arise under" federal law for federal-court jurisdiction when Congress intended no private federal remedy, so removal was improper.

Real World Impact:

Keeps many drug-injury lawsuits in state courts rather than federal courts.
Limits removal when a federal statute provides no private remedy.
Reduces federal courts' routine role in hearing state torts that cite federal standards.

Topics: product liability, federal jurisdiction, drug labeling, state torts

Summary

Background

A group of parents who live in Canada and Scotland sued an Ohio drug company after their children were born with birth defects they said were caused by the drug Bendectin. They filed several state-law claims in Ohio courts — negligence, strict liability, breach of warranty, and one count saying the drug was "misbranded" under the Federal Food, Drug, and Cosmetic Act (FDCA). The company removed the cases to federal court, and the lower courts disagreed about whether the case belonged in federal court.

Reasoning

The central question was whether using a federal law as proof inside a state-law claim makes the case a federal case. The Court assumed Congress had not created a private federal cause of action under the FDCA. It applied the standard that a federal court gets jurisdiction only when the plaintiff’s claim itself depends on federal law. The Court held that where Congress intended no private federal remedy, simply labeling a state tort claim with a violation of a federal statute is not enough to make the case arise under federal law. The Court rejected arguments that novelty or the need for uniform federal interpretation alone should move the case to federal court.

Real world impact

As a result, many injury suits that use federal standards but are crafted as state-law claims will stay in state courts rather than being heard in federal court. That means fewer automatic federal forums for product-liability suits that invoke federal statutes where Congress withheld private remedies. The Supreme Court noted, however, that federal law questions decided in state courts can still reach this Court on appeal.

Dissents or concurrances

A four-Justice dissent argued federal courts should hear claims when a federal question is an essential ingredient and disagreed that Congress' withholding of a private remedy bars federal jurisdiction.